Resmed Inc banner

Wall St Price Targets

RMEA Price Targets Summary
Resmed Inc

Wall Street analysts forecast RMEA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RMEA is 24.7 EUR with a low forecast of 18.97 EUR and a high forecast of 29.58 EUR.

Lowest Forecast
Price Target
18.97 EUR
8% Upside
Average Forecast
Price Target
24.7 EUR
40% Upside
Highest Forecast
Price Target
29.58 EUR
68% Upside
Resmed Inc Competitors:
Price Targets
GWH
ESS Tech Inc
124% Upside

Revenue
Forecast

11% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
11% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 5 years is 9%.

Operating Income
Forecast

14% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
14% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 5 years is 11%.

Net Income
Forecast

14% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
14% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 5 years is 11%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is RMEA's stock price target?
Price Target
24.7 EUR

According to Wall Street analysts, the average 1-year price target for RMEA is 24.7 EUR with a low forecast of 18.97 EUR and a high forecast of 29.58 EUR.

What is the Revenue forecast for Resmed Inc?
Projected CAGR
9%

Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 5 years is 9%.

What is the Operating Income forecast for Resmed Inc?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 5 years is 11%.

What is the Net Income forecast for Resmed Inc?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 5 years is 11%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett